ARCH Venture Partners XII LLC insider trades
Open-market stock purchases and sales by ARCH Venture Partners XII LLC, 10% Owner at City Therapeutics, Inc, from SEC Form 4 filings since Sep 22, 2023.
Track record: 17% of 24 scored buys are up 5% or more since purchase, averaging -52%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 19, 2026 | CTY City Therapeutics, Inc | Bought (not open market) | $3.1M |
| Oct 19, 2026 | CTY City Therapeutics, Inc | Bought (not open market) | — |
| Oct 19, 2026 | CTY City Therapeutics, Inc | Bought (not open market) | — |
| Oct 19, 2026 | CTY City Therapeutics, Inc | Bought (not open market) | — |
| Oct 19, 2026 | CTY City Therapeutics, Inc | Bought (not open market) | — |
| Oct 19, 2026 | CTY City Therapeutics, Inc | Bought (not open market) | — |
| Oct 19, 2026 | CTY City Therapeutics, Inc | Bought (not open market) | — |
| May 4, 2026 | SPTX Seaport Therapeutics, Inc | Bought (not open market) | — |
| May 4, 2026 | SPTX Seaport Therapeutics, Inc | Bought | $19.8M |
| May 4, 2026 | SPTX Seaport Therapeutics, Inc | Bought (not open market) | — |
| Nov 13, 2025 | MTSR Metsera, Inc | Sold (not open market) | — |
| Nov 13, 2025 | MTSR Metsera, Inc | Sold (not open market) | — |
| Oct 27, 2025 | NMRA Neumora Therapeutics, Inc | Bought | $5M |
Companies traded
- CTY City Therapeutics, Inc: other filings, last Oct 19, 2026
- SPTX Seaport Therapeutics, Inc: 1 buy, last May 4, 2026
- MTSR Metsera, Inc: 2 buys, last Nov 13, 2025
- NMRA Neumora Therapeutics, Inc: 19 buys, last Oct 27, 2025
- PRME Prime Medicine, Inc: 2 buys, last Aug 1, 2025
- RAPP Rapport Therapeutics, Inc: other filings, last Jun 10, 2024
Get free alerts when ARCH Venture Partners XII LLC files a new trade →